GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » 2cureX AB (OSTO:2CUREX) » Definitions » Float Percentage Of Total Shares Outstanding

2cureX AB (OSTO:2CUREX) Float Percentage Of Total Shares Outstanding : 0.00% (As of Dec. 12, 2024)


View and export this data going back to 2017. Start your Free Trial

What is 2cureX AB Float Percentage Of Total Shares Outstanding?

Float percentage of total shares outstanding is the percentage of float shares relative to the total shares outstanding. As of today, 2cureX AB's float shares is 0.00 Mil. 2cureX AB's total shares outstanding is 17.60 Mil. 2cureX AB's float percentage of total shares outstanding is 0.00%.

Insider Ownership is the percentage of shares that are owned by company insiders relative to the total shares outstanding. As of today, 2cureX AB's Insider Ownership is 0.00%.

Institutional Ownership is the percentage of shares that are owned by institutions out of the total shares outstanding. As of today, 2cureX AB's Institutional Ownership is 0.01%.

2cureX AB Float Percentage Of Total Shares Outstanding Calculation

It is the percentage of float shares out of the total shares outstanding.

2cureX AB's Float Percentage of Total Shares Outstanding for today is calculated as follows:

Float Percentage of Total Shares Outstanding=Float Shares/Total Shares Outstanding
=0.00/17.60
=0.00%

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

2cureX AB Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » 2cureX AB (OSTO:2CUREX) » Definitions » Float Percentage Of Total Shares Outstanding
Comparable Companies
OSTO:LPGO XSAT:CHOSA OSTO:SCOL OSTO:EXPRS2 OSTO:COMBI XSAT:ABERA NGM:COEGIN XSAT:APTA XSAT:DBP B OSTO:ONCOZ OCSE:NOVO B VRTX REGN ASX:CSL SGEN XKRX:207940 MRNA HKSE:02269 XBRU:ARGX BNTX
Traded in Other Exchanges
2QE:Germany
Address
Fruebjergvej 3, Copenhagen, DNK, DK-2100
Website
https://www.2curex.com
2cureX AB is a biotech company. The company is engaged in improving treatment efficiency, mainly for cancer patients. It is involved in developing a product, namely IndiTreat, which is a technology for the treatment of colorectal, ovarian, and pancreatic cancers. The company's sub-products include IndiTreat Test, IndiTreat clinical programs, and IndiTreat Therapy Design.

2cureX AB Headlines

No Headlines